Centro de Apresentações

Centro de Apresentações

Bem-vindo ao nosso Centro de Apresentações, onde pode criar, editar, guardar e exportar apresentações personalizadas.

Introduza pelo menos 3 caracteres
Featured
MAIS RECENTE

Conteúdo Recomendado

COVID-19 and its implications in heart failure
APRESENTAÇÃO
COVID-19 and its implications in heart failure
Ver Conteúdo
Can new-onset diabetes be prevented
APRESENTAÇÃO
Can new-onset diabetes be prevented
Ver Conteúdo
Practicalities of SGLT2 inhibition – pros vs cons
INFOGRAPHIC
Practicalities of SGLT2 inhibition – pros vs cons
Ver Conteúdo
Updates on ESC heart failure guidelines
VIDEO
Updates on ESC heart failure guidelines
Ver Conteúdo
Cardiologist Practical Guide to Prescribing
INFOGRAPHIC
Cardiologist Practical Guide to Prescribing
Ver Conteúdo
Cardiovascular
MAIS RECENTE

Cardiovascular

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
APRESENTAÇÃO
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Ver Conteúdo
What did the study tell us about the safety of medicines in heart failure?
APRESENTAÇÃO
What did the study tell us about the safety of medicines in heart failure?
Ver Conteúdo
Hiding in plain sight – how to detect heart failure in primary care
APRESENTAÇÃO
Hiding in plain sight – how to detect heart failure in primary care
Ver Conteúdo
Optimizing HF discharge care and follow-up
APRESENTAÇÃO
Optimizing HF discharge care and follow-up
Ver Conteúdo
Ver todas Cardiovascular apresentações
Infection and Vaccines
MAIS RECENTE

Infecção e vacinas

Hiding in plain sight – how to detect heart failure in primary care
APRESENTAÇÃO
Hiding in plain sight – how to detect heart failure in primary care
Ver Conteúdo
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
APRESENTAÇÃO
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Ver Conteúdo
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
APRESENTAÇÃO
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Ver Conteúdo
Kidney outcomes associated with inhibition of SGLT2
APRESENTAÇÃO
Kidney outcomes associated with inhibition of SGLT2
Ver Conteúdo
Ver todas Infecção e vacinas apresentações
Metabolic
MAIS RECENTE

Metabólica

Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
APRESENTAÇÃO
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Ver Conteúdo
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
APRESENTAÇÃO
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Ver Conteúdo
Clinical recommendations for the management of type 2 diabetes
APRESENTAÇÃO
Clinical recommendations for the management of type 2 diabetes
Ver Conteúdo
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
APRESENTAÇÃO
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Ver Conteúdo
Ver todas Metabólica apresentações
Oncology
MAIS RECENTE

Oncologia

What did the study tell us about the safety of medicines in heart failure?
APRESENTAÇÃO
What did the study tell us about the safety of medicines in heart failure?
Ver Conteúdo
Clinical recommendations for the management of type 2 diabetes
APRESENTAÇÃO
Clinical recommendations for the management of type 2 diabetes
Ver Conteúdo
Kidney outcomes associated with inhibition of SGLT2
APRESENTAÇÃO
Kidney outcomes associated with inhibition of SGLT2
Ver Conteúdo
Medicines in chronic kidney disease
APRESENTAÇÃO
Medicines in chronic kidney disease
Ver Conteúdo
Ver todas Oncologia apresentações
Rare Disease
MAIS RECENTE

Rare Disease

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
APRESENTAÇÃO
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Ver Conteúdo
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
APRESENTAÇÃO
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Ver Conteúdo
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
APRESENTAÇÃO
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Ver Conteúdo
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
APRESENTAÇÃO
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Ver Conteúdo
Ver todas Rare Disease apresentações
Renal
MAIS RECENTE

Renal

Chronic kidney disease management
APRESENTAÇÃO
Chronic kidney disease management
Ver Conteúdo
Renal protection with SGLT2 inhibitors: what every cardiologist should know
APRESENTAÇÃO
Renal protection with SGLT2 inhibitors: what every cardiologist should know
Ver Conteúdo
Kidney outcomes associated with inhibition of SGLT2
APRESENTAÇÃO
Kidney outcomes associated with inhibition of SGLT2
Ver Conteúdo
Medicines in chronic kidney disease
APRESENTAÇÃO
Medicines in chronic kidney disease
Ver Conteúdo
Ver todas Renal apresentações
Respiratory and Immunology
MAIS RECENTE

Comunologia respiratória e imunologa

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
APRESENTAÇÃO
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Ver Conteúdo
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
APRESENTAÇÃO
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Ver Conteúdo
Chronic kidney disease management
APRESENTAÇÃO
Chronic kidney disease management
Ver Conteúdo
Kidney outcomes associated with inhibition of SGLT2
APRESENTAÇÃO
Kidney outcomes associated with inhibition of SGLT2
Ver Conteúdo
Ver todas Comunologia respiratória e imunologa apresentações
Apresentado
MAIS RECENTE

Tendência de conteúdos

The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
APRESENTAÇÃO
The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
Ver Conteúdo
Cardiologist Practical Guide to Prescribing
INFOGRAPHIC
Cardiologist Practical Guide to Prescribing
Ver Conteúdo
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
VIDEO
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
Ver Conteúdo
Cardiorenal benefits of SGLT2 inhibitors
APRESENTAÇÃO
Cardiorenal benefits of SGLT2 inhibitors
Ver Conteúdo
Diagnosis and co-morbidities of chronic kidney disease
VIDEO
Diagnosis and co-morbidities of chronic kidney disease
Ver Conteúdo